Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

This bill allows pharmacists to replace brand-name epinephrine auto-injectors with lower-cost generic versions when treating patients. The substitution is permitted only if the generic product contains the same active ingredients and strength, the doctor has not explicitly requested the brand name, and the patient agrees to the switch after being informed of the option. Additionally, the pharmacist must provide counseling on how to properly use the device. The law aims to reduce costs for purchasers while ensuring that the medical device remains effective and safe.